Interim Report 1 2017-01-01 – 2017-03-31
Oncology Venture Sweden AB (publ) | 559016-3290The Board and CEO of Oncology Venture Sweden AB hereby announces the Interim Report for the first quarter of 2017. “Oncology Venture Sweden AB” refers to Oncology Venture Sweden AB, organisation no 559016-3290. ”The Company”, or ”Oncology Venture” refers to the business group, i.e. Oncology Venture Sweden AB and subsidiaries Oncology Venture ApS (100% ownership), 2X Oncology (92 % ownership share) and OV-SPV2 ApS (80 % ownership share). Summary of Interim Report First Quarter (2017-01-01 – 2017-03-31) · Net sales: 0 SEK (1 478